PANTERA

Last week we organized a townhall for our team to celebrate our successes of 2024 and look forward to all the adventures ahead of us in 2025! Here are a few of our key milestones that we have achieved in 2024 💪 ✒️ Signed purchase of our terrain 💲 Raised more than 130M€ (95M€ equity) 🧪 Started the distribution of #Ac225! 📐 Created the full 3D model of our Production Center (start of construction in September 2025) 🏭 Designed and ordered our Industrial Building (complete by mid 2025) ☢️ Ordered our first hot cells ⚡Performed crucial de-risking experiments We want to thank everyone who supported us in achieving these key milestones, we are excited to continue these collaborations‼️

PanTera stood proudly on stage yesterday evening at the M&A Awards. We were selected as Belgium's best venture capital deal in life sciences for 2024 by a jury of experts in the field of investment. Of course, this is another occasion to thank our investors EQT Group, Kurma Partners, Eurazeo, Paladin Capital Group, Korys, PMV and SFPIM. The syndicate was expanded today with Wallonie Entreprendre, which in itself is already a reason to celebrate ! Our adventure would have been impossible without our founders IBA and SCK CEN ! It takes a village to seal these deals, so we are grateful for the assistance of KBC Securities and Cambrian, but certainly not in the least to the entire PanTera team which continues to grow ! Thank you for shaping our beautiful adventure and allowing us to tell it on your behalf ! Finally, PanTera dedicates this award to the millions of cancer patients and their families around the world and promises them we will continue to provide hope for a Better Fight for Life !

PanTera stood proudly on stage yesterday evening at the M&A Awards. We were selected as Belgium's best venture capital deal in life sciences for 2024 by a jury of experts in the field of investment. Of course, this is another occasion to thank our investors EQT Group, Kurma Partners, Eurazeo, Paladin Capital Group, Korys, PMV and SFPIM. The syndicate was expanded today with Wallonie Entreprendre, which in itself is already a reason to celebrate ! Our adventure would have been impossible without our founders IBA and SCK CEN ! It takes a village to seal these deals, so we are grateful for the assistance of KBC Securities and Cambrian, but certainly not in the least to the entire PanTera team which continues to grow ! Thank you for shaping our beautiful adventure and allowing us to tell it on your behalf ! Finally, PanTera dedicates this award to the millions of cancer patients and their families around the world and promises them we will continue to provide hope for a Better Fight for Life !

PanTera stood proudly on stage yesterday evening at the M&A Awards. We were selected as Belgium's best venture capital deal in life sciences for 2024 by a jury of experts in the field of investment. Of course, this is another occasion to thank our investors EQT Group, Kurma Partners, Eurazeo, Paladin Capital Group, Korys, PMV and SFPIM. The syndicate was expanded today with Wallonie Entreprendre, which in itself is already a reason to celebrate ! Our adventure would have been impossible without our founders IBA and SCK CEN ! It takes a village to seal these deals, so we are grateful for the assistance of KBC Securities and Cambrian, but certainly not in the least to the entire PanTera team which continues to grow ! Thank you for shaping our beautiful adventure and allowing us to tell it on your behalf ! Finally, PanTera dedicates this award to the millions of cancer patients and their families around the world and promises them we will continue to provide hope for a Better Fight for Life !

First award of the evening at the M&A Awards 2024 and PMV has its first win! PANTERA wins the Venture Award of the year in the Life Sciences category. Congrats to Kenneth W. and team! Congrats to the PANTERA team!

🌟 Celebrating excellence at the M&A Awards 2024! 🌟 After a rigorous selection process supported by our Knowledge Partner, Vlerick Business School, the esteemed jury reviewed over 100 pitches from the M&A community. From these, 18 outstanding finalists across six categories emerged, along with a Lifetime Achievement Award winner. 🏆 𝗧𝗵𝗲 𝗪𝗶𝗻𝗻𝗲𝗿𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗔𝘄𝗮𝗿𝗱𝘀 𝟮𝟬𝟮𝟰 Best Large Cap Corporate Deal: CMB.TECH acquires Euronav Best Mid Cap Corporate Deal: Axcent of Scandinavia and SKEL acquire INNO Best Large Cap Private Equity Exit: Summit Partners exits CluePoints Best Mid Cap Private Equity Exit: Smile Invest exits SmartSD Benelux Best Venture Capital Deal – Technology: Aikido Security Best Venture Capital Deal – Life Sciences: PANTERA Lifetime Achievement Award: Wim Dejonghe 👏 𝗖𝗼𝗻𝗴𝗿𝗮𝘁𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗮𝗹𝗹 𝘁𝗵𝗲 𝘄𝗶𝗻𝗻𝗲𝗿𝘀 𝗮𝗻𝗱 𝘁𝗵𝗲𝗶𝗿 𝗮𝗱𝘃𝗶𝘀𝗼𝗿𝘀! A heartfelt thank you to our jury members for their dedication: Lieve Creten, Renaat Berckmoes, Pierre Demaerel, Philippe Haspeslagh, Sophie Manigart, Michael Sephiha and An Vermeersch. Special thanks to our sponsors: Principal Sponsor: Ansarada, our Platinum Partner: PwC Belgium and our Sponsor: Howden 📅 Save the Date The next edition, M&A Awards 2025, will take place on December 4th, 2025. Secure your table today - https://lnkd.in/ebPyEcbv 📸 Vincent Gorissen

PANTERA, the Belgian radioisotope producer, has completed a US$104.1 million (€93 million) Series A fundraise, which was led by EQT Life Sciences and oversubscribed. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round also included Kurma Partners, Eurazeo, Korys, Paladin and PMV. Oaklins’ team in Belgium acted as the sole financial advisor in this transaction. It highlights Oaklins’ experience across a range of financial ventures and growth strategies, and its expertise in identifying viable partnerships and collaborations. Deal team: Cedric Michils, Bart Delusinne, Nicolas Lambers, Michaël Rixhon, Nicholas Matthyssens, Robin Bundervoet and Niels Maes View more deals in Healthcare: https://lnkd.in/eti2JGxC #Oaklins #MergersAndAquisitions #Healthcare

A big thank you to the PANTERA team for three intensive and inspiring days focused on developing the best solutions for large-scale Ac-225 production. We are thrilled to make this exciting new journey together! #ComecerForRadiopharma

🧬⚛️Happening this week: Second International Workshop on Medical Radioisotopes Supply ⚛️🧬 The OECD Nuclear Energy Agency gathered governmental decision makers, private sector representatives, health organisations and researchers to chart the development of secure supply chains for conventional and innovative nuclear radioisotopes in the medical field. 🌍 Co-organised with the U.S. Department of Energy (DOE) and the European Commission’s Joint Research Centre, the 2024 edition in Paris adds a focus on the market potential of Lutetium-177 (Lu-177), Actinium (Ac-225) and other innovative medical radioisotopes, strengthening the medical radioisotope supply chain’s resiliency through monitoring supply and demand and critical infrastructure needs across medical systems. 🏥💉 More about the event 🖱️ https://lnkd.in/ecqM8RMP

Come and meet our PANTERA Team at the European Association of Nuclear Medicine (EANM) conference. Samy Bertrand, Christophe Malice, Yves Sterckx and Sven Van den Berghe will be there, together with some of our experts. You can find us at📍H27, together with IBA RadioPharma Solutions. Make sure to also visit SCK CEN at📍H32 to get an answer to your R&D questions. Some of our new investors are thrilled to also join us at the conference! 🤝 We are eager to engage with you on several topics. ✅ We will gladly elaborate on how PANTERA can meet your needs for pure Ac-225 with our plan for Short-term and Long-term supply.